Highlights

  • CleanSpace Holdings shares rose 6.25% to AUD 0.34 during morning trade on 11 June 2026.
  • The company launched CleanSpace AGILE, described as the world's first loose-fitting Powered Air Purifying Respirator (PAPR) using patented AirSensit® technology.
  • AGILE achieved European EN 12941 (TH2) certification, enabling commercial access to the company's largest revenue-generating market.
  • The product delivers 99.97% filtration efficiency and was developed following nearly two years of research and development.

CleanSpace Holdings Ltd (ASX:CSX) attracted investor attention during the morning session on 11 June 2026, with its shares climbing 6.25% to AUD 0.34 after the company announced the commercial launch of a new respiratory protection product and the achievement of an important European regulatory milestone.

The positive share price movement followed the release of details regarding CleanSpace AGILE, a new powered air purifying respirator designed for industrial environments. The announcement also confirmed that the product had successfully secured EN 12941 (TH2) certification in Europe, allowing the company to begin supplying the product through its authorised distribution network across the United Kingdom and broader European region.

While the stock remains down 17.07% over the past year, investors appeared encouraged by a development that expands CleanSpace's product portfolio and provides access to additional commercial opportunities within one of its most established markets.

About CleanSpace Holdings

CleanSpace Holdings is a Sydney-based designer and manufacturer of respiratory protection equipment serving both industrial and healthcare sectors. The company was founded by biomedical engineers with experience in respiratory medical devices and focuses on developing respiratory protection systems that combine advanced technology with user-focused design.

Over the years, CleanSpace has invested heavily in research and development to create differentiated respiratory protection products that aim to improve workplace safety, health outcomes and compliance across a range of industries. Its portfolio is supported by proprietary technologies and patented innovations designed to meet evolving regulatory and workplace requirements.

The company continues to focus on delivering respiratory protection solutions that address challenges faced by workers in environments where exposure to airborne contaminants presents health and safety risks.

New Product Launch Marks Important Commercial Milestone

At the centre of the latest announcement is the launch of CleanSpace AGILE, a new respiratory protection device developed specifically for industrial settings where workers are exposed to high levels of airborne particulates and dust.

According to the company, AGILE is the world's first loose-fitting Powered Air Purifying Respirator powered by its patented AirSensit® technology. The product has been designed to provide respiratory protection while maintaining comfort, mobility and ease of use for workers operating in demanding environments.

The launch represents the culmination of almost two years of focused development work undertaken by CleanSpace's engineering and product teams.

Management noted that the product was developed in response to increasingly rigorous regulatory requirements in developed respiratory protection markets while also addressing the practical needs of workers who may face challenges using conventional respiratory protection equipment.

European Certification Unlocks New Market Access

A key aspect of the announcement was the successful achievement of EN 12941 (TH2) certification for AGILE.

The certification process involved extensive testing and validation to ensure compliance with European regulatory requirements for loose-fitting powered air purifying respirators.

Obtaining this approval allows CleanSpace to commercially offer AGILE throughout Europe, which currently represents the company's largest market by revenue.

The company highlighted that the certification process is both rigorous and time-consuming, making the achievement an important operational and commercial milestone.

Beyond enabling market access, management believes the approval further validates the product's technical credentials and reinforces the company's position within a regulatory environment where compliance standards continue to evolve.

The certification also provides CleanSpace with an opportunity to strengthen its presence in industrial respiratory protection markets while expanding customer choice through an additional product offering.

Designed to Address Industrial Workplace Requirements

CleanSpace AGILE has been developed specifically for industries where dust exposure and airborne particulates create ongoing workplace safety challenges.

One of the product's distinguishing features is its loose-fitting half-facepiece design, which has been engineered to accommodate a broad range of users, including workers with facial hair.

Traditional respiratory protection solutions can sometimes create challenges for individuals who are unable to achieve the seal required for certain tight-fitting devices. The AGILE design aims to address this issue while maintaining high levels of filtration performance.

According to the company, the product delivers 99.97% filtration efficiency and incorporates a lightweight design weighing less than 425 grams.

The absence of belts and hoses is intended to improve mobility and comfort, while compatibility with other personal protective equipment allows workers to integrate AGILE into existing workplace safety protocols.

The company also emphasised that the product has been designed for ease of use, enabling workers to put on and remove the device efficiently during day-to-day operations.

Benefits Extend Beyond Worker Protection

While respiratory safety remains the primary objective, CleanSpace believes AGILE can also provide operational benefits for employers and organisations.

The company noted that improved comfort and usability can contribute to stronger worker adoption rates, which may assist organisations in maintaining compliance with respiratory protection programs.

Enhanced ergonomics and lightweight design may also support productivity by reducing discomfort during extended periods of use.

For employers operating within increasingly regulated industries, the combination of regulatory compliance, worker acceptance and respiratory protection can represent an important consideration when selecting workplace safety equipment.

CleanSpace believes these factors position AGILE as a compelling option across a range of industrial applications.

Targeting Large Industrial End Markets

The company views AGILE as an opportunity to expand its presence across several industrial sectors where respiratory protection remains a critical workplace requirement.

Industries identified by CleanSpace include construction, quarrying, mining, manufacturing and other environments where workers are exposed to airborne particulate hazards.

These sectors continue to face evolving occupational health and safety requirements, creating demand for respiratory protection solutions capable of meeting increasingly stringent standards.

Management believes the combination of regulatory drivers and heightened awareness of worker health is supporting a sizeable addressable market across Europe and other developed regions.

The launch of AGILE enhances the company's ability to pursue opportunities in both existing customer segments and new industrial applications.

Australian and New Zealand Approval Represents the Next Step

While Europe represents the initial commercial focus following certification, CleanSpace also provided an update regarding regulatory progress in Australia and New Zealand.

The company stated that approval for these markets remains on track and is expected within the coming months.

If achieved as anticipated, the certification would further expand the potential customer base for AGILE and increase the number of regions where the product can be commercially distributed.

Management believes the additional approvals would materially broaden the addressable market and support wider adoption of the technology.

The company is currently focused on progressing commercialisation activities while preparing for future market expansion opportunities.

Innovation Remains Central to Growth Strategy

The development of AGILE highlights the company's ongoing commitment to innovation and product development.

CleanSpace stated that the project reflects nearly two years of concentrated work by its research, engineering and product teams.

The company continues to invest in research and development programs aimed at creating differentiated respiratory protection solutions that align with customer requirements and changing regulatory expectations.

Its portfolio of patented technologies remains a key element of this strategy, supporting product differentiation in a competitive global market.

Management views continued innovation as an important component of maintaining relevance in industries where safety standards and user expectations continue to evolve.

What This Means for Investors?

CleanSpace's latest announcement represents both a product development achievement and a commercial expansion opportunity. The successful launch of AGILE, combined with European regulatory approval, provides access to additional industrial markets and strengthens the company's product offering within its largest revenue-generating region.

The development appears to have been viewed positively by investors because it combines a new product launch with a certification milestone that enables immediate commercialisation. With Australian and New Zealand approvals also progressing, market participants may continue monitoring the company's ability to expand adoption of AGILE across key industrial sectors and execute on its broader commercialisation strategy.